Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 28 Mar 2023

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study

in Hematologic Malignancies

Youngwoo Jeon
Duk-Hwan Yang
Suk-Joong Oh
Jin-Hee Park
Jung-Ah Kim
Sung-Young Kim
Chul-Won Choi
Won-Sik Lee
In-Ho Kim
Yeung-Chul Mun

Frontiers in Oncology

doi 10.3389/fonc.2023.998014

3,150 views
3 citations

Editorial

Published on 28 Mar 2023

Editorial: Advances in the understanding and treatment of cutaneous lymphoma

in Hematologic Malignancies

Andrea Bernardelli
Lorenzo Falchi
Jianjun Qiao
Carlo Visco

Frontiers in Oncology

doi 10.3389/fonc.2023.1190269

2,064 views
1 citation

Original Research

Published on 27 Mar 2023

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia

in Hematologic Malignancies

Mariarita Sciumè
Alessandro Bosi
Marta Canzi
Giusy Ceparano
Fabio Serpenti
Pasquale De Roberto
Sonia Fabris
Elena Tagliaferri
Francesca Cavallaro
Francesco Onida

Frontiers in Oncology

doi 10.3389/fonc.2023.1149298

4,653 views
15 citations

Case Report

Published on 27 Mar 2023

Interpreting flow cytometry with caution: A case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

in Hematologic Malignancies

Yuan Ren
Congwei Jia
Miao Chen
Wei Wang
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1170598

4,589 views
1 citation

Review

Published on 24 Mar 2023

The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma

in Hematologic Malignancies

Marion Lacroix
Hugues Beauchemin
Cyrus Khandanpour
Tarik Möröy

Frontiers in Oncology

doi 10.3389/fonc.2023.1148936

9,647 views
10 citations

Editorial

Published on 24 Mar 2023

Editorial: Inflammation and blood diseases, a dog chasing its tail

in Hematologic Malignancies

Cosimo Cumbo
Francesco Tarantini
Michele Gottardi
Francesco Albano

Frontiers in Oncology

doi 10.3389/fonc.2023.1180559

1,587 views

Editorial

Published on 23 Mar 2023

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies

in Hematologic Malignancies

Andreas Agathangelidis
Manlio Ferrarini
Franco Fais

Frontiers in Oncology

doi 10.3389/fonc.2023.1188375

1,267 views

Original Research

Published on 23 Mar 2023

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT

in Hematologic Malignancies

Zhangjie Chen
Sisi Zhen
Tingting Zhang
Yuyan Shen
Aiming Pang
Donglin Yang
Rongli Zhang
Qiaoling Ma
Yi He
Jialin Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1137175

5,079 views
10 citations

Review

Published on 23 Mar 2023

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions

in Hematologic Malignancies

Anna Wolska-Washer
Tadeusz Robak

Frontiers in Oncology

doi 10.3389/fonc.2023.1130595

17,221 views
17 citations

Review

Published on 21 Mar 2023

Precision diagnostics in chronic lymphocytic leukemia: Past, present and future

in Hematologic Malignancies

John Mollstedt
Larry Mansouri
Richard Rosenquist

Frontiers in Oncology

doi 10.3389/fonc.2023.1146486

8,631 views
17 citations

Review

Published on 17 Mar 2023

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process

in Hematologic Malignancies

Moqin Jiang
Meng Chen
Qian Liu
Zhiling Jin
Xiangdong Yang
Weifeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1116438

26,860 views
26 citations

Original Research

Published on 17 Mar 2023

CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring

in Hematologic Malignancies

Stefano Vergani
Davide Bagnara
Andreas Agathangelidis
Anita Kar Yun Ng
Gerardo Ferrer
Andrea N. Mazzarello
Florencia Palacios
Sophia Yancopoulos
Xiao-Jie Yan
Jaqueline C. Barrientos

Frontiers in Oncology

doi 10.3389/fonc.2023.1112879

5,819 views
7 citations

Case Report

Published on 16 Mar 2023

Pathological fracture due to primary bone lymphoma in a patient with a history of prostate cancer: A case report and review of literature

in Hematologic Malignancies

Pooja Bhakta
Zachary E. Hunzeker
Juan D. Garcia
Ayman Youssef
Bradley J. Grant
Rasha Alfattal
Dylan Weaver
Peeyush Bhargava
Ariel Rischall
Tejo Musunuru

Frontiers in Oncology

doi 10.3389/fonc.2023.1100559

4,401 views
1 citation

Original Research

Published on 16 Mar 2023

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience

in Hematologic Malignancies

Tamara Chitanava
Iuliia Matvienko
Vasily Shuvaev
Sergey Voloshin
Irina Martynkevich
Yulia Vlasova
Elizaveta Efremova
Ekaterina Mileeva
Anna Pirkhalo
Taiana Makarova

Frontiers in Oncology

doi 10.3389/fonc.2023.1138683

3,632 views
2 citations

Brief Research Report

Published on 15 Mar 2023

Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption

in Hematologic Malignancies

Sarah Morin
Federica Giannotti
Anne-Claire Mamez
Amandine Pradier
Stavroula Masouridi-Levrat
Federico Simonetta
Yves Chalandon

Frontiers in Oncology

doi 10.3389/fonc.2023.1095870

4,347 views
16 citations

Review

Published on 15 Mar 2023

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis

in Hematologic Malignancies

Valentina Svicher
Romina Salpini
Stefano D’Anna
Lorenzo Piermatteo
Marco Iannetta
Vincenzo Malagnino
Loredana Sarmati

Frontiers in Oncology

doi 10.3389/fonc.2023.1143258

4,579 views
10 citations

Case Report

Published on 15 Mar 2023

Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment

in Hematologic Malignancies

Carine Tabak
Stephen Hyter
Abdulraheem Yacoub
Kenneth Byrd
Joseph McGuirk
Andrew K. Godwin
Haitham Abdelhakim

Frontiers in Oncology

doi 10.3389/fonc.2023.1017230

3,069 views

Case Report

Published on 14 Mar 2023

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia

in Hematologic Malignancies

Wei Yuan
Zhen Shang
Kefeng Shen
Qiuxia Yu
Qiuxia Lv
Yang Cao
Jue Wang
Yi Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1066083

2,629 views
3 citations

Review

Published on 14 Mar 2023

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?

in Hematologic Malignancies

Giovanni Manfredi Assanto
Ilaria Del Giudice
Irene Della Starza
Roberta Soscia
Marzia Cavalli
Mattia Cola
Vittorio Bellomarino
Mariangela Di Trani
Anna Guarini
Robin Foà

Frontiers in Oncology

doi 10.3389/fonc.2023.1152467

4,176 views
2 citations

Original Research

Published on 14 Mar 2023

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma

in Hematologic Malignancies

Susanne Ghandili
Judith Dierlamm
Carsten Bokemeyer
Clara Marie von Bargen
Sören Alexander Weidemann

Frontiers in Oncology

doi 10.3389/fonc.2023.1146029

2,331 views
1 citation

Original Research

Published on 10 Mar 2023

Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study

in Hematologic Malignancies

Yu-tong Wang
Bin Chu
Tian-guan Zhou
Min-qiu Lu
Lei Shi
Shan Gao
Li-juan Fang
Qiu-qing Xiang
Xin- Zhao
Meng-zhen Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1110693

4,754 views
6 citations

Review

Published on 10 Mar 2023

LSD1 inhibition modulates transcription factor networks in myeloid malignancies

in Hematologic Malignancies

Emily E. Hartung
Kanwaldeep Singh
Tobias Berg

Frontiers in Oncology

doi 10.3389/fonc.2023.1149754

9,165 views
9 citations

Brief Research Report

Published on 10 Mar 2023

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi

in Hematologic Malignancies

Gloria Margiotta-Casaluci
Sara Bigliardi
Federica Cocito
Erika Meli
Luigi Petrucci
Maura Nicolosi
Ombretta Annibali
Carola Boccomini
Valentina Bozzoli
Alessia Castellino

Frontiers in Oncology

doi 10.3389/fonc.2023.1120967

6,690 views
6 citations

Editorial

Published on 09 Mar 2023

Editorial: Advances in the treatment of chronic myeloid leukemia

in Hematologic Malignancies

Ahmet Emre Eşkazan
Chung H. Kok
David Yeung
Jignesh Dalal
Mario Tiribelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1166588

3,434 views
6 citations

2,053 articles

articles

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study

Editorial: Advances in the understanding and treatment of cutaneous lymphoma

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia

Interpreting flow cytometry with caution: A case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma

Editorial: Inflammation and blood diseases, a dog chasing its tail

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions

Precision diagnostics in chronic lymphocytic leukemia: Past, present and future

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process

CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring

Pathological fracture due to primary bone lymphoma in a patient with a history of prostate cancer: A case report and review of literature

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience

Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis

Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma

Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study

LSD1 inhibition modulates transcription factor networks in myeloid malignancies

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi

Editorial: Advances in the treatment of chronic myeloid leukemia